Table 3.

Perceived MOUD Barriers of total pilot sample and subsamples.

	Total (N=36) N (%)	Subsample (n=19) N (%)	Excluded (n =17) N (%)
Health Concerns
Pregnant	0 (0%)	0 (0%)	0 (0%)
Chronic pain condition	22 (62.9%)	12 (66.7%)	10 (58.8%)
Chronic Pain intensity
Mild	1 (4.6%)	1 (8.3%)	0 (0%)
Moderate	9 (40.9%)	7 (58.3%)	2 (20.0%)
Severe	12 (54.6%)	4 (33.3%)	8 (80%)
Liver disease (e.g., Hep.C)	12 (33.3%)	8 (42.1%)	4 (23.5%)
Other substance use	27 (75%)	12 (63.2%)	15 (88.2%)
Other health problems	14 (38.9%)	9 (47.4%)	5 (29.4%)
Other medical concerns	5 (14.3%)	1 (5.6%)	4 (23.5%)
Other mental health concerns	22 (62.9%)	10 (55.6%)	12 (70.6%)
HIV positive	2 (5.6%)	0 (0%)	2 (11.8%)
Other	5 (15.2%)	4 (23.5%)	1 (6.3%)
Barriers to Treatment
Treatment cost	14 (38.9%)	7 (36.8%)	7 (41.2%)
Take time off from work	9 (25%)	5 (26.3%)	4 (23.5%)
Transportation	13 (36.1%)	5 (26.3%)	8 (47.1%)
Child care	2 (5.6%)	1 (5.3%)	1 (5.9%)
Others might judge me	11 (30.6%)	7 (36.8%)	4 (23.5%)
Physical/Medical limitations	7 (19.4%)	4 (21.1%)	3 (17.7%)
Other:	9 (25.7%)	6 (33.3%)	3 (17.7%)

Subsample = Participants with an OUD diagnosis in EHR over 3 months.

Excluded= Pilot testing participants without an OUD diagnosis in EHR over 3 months.